OCUL
Ocular Therapeutix, Inc.
NASDAQHealthcareBiotechnologyUS
Rating:C-
Company Profile
CEO
Pravin U. Dugel
IPO Date
2014-07-25
Sector
Healthcare
Industry
Biotechnology
Exchange
NASDAQ
Country
US
Ocular Therapeutix, Inc.
CEO
Pravin U. Dugel
IPO Date
2014-07-25
Sector
Healthcare
Industry
Biotechnology
Exchange
NASDAQ
Country
US
| 394,696 |
| $0.00 |
| 28 May 2026 | Dugel Pravin | director, officer: See Remarks | G-Gift | Acquired | 394,696 | $0.00 |
| 28 May 2026 | Kaiser Peter | Chief Development Officer | S-Sale | Disposed | 2,967 | $8.20 |
| 28 May 2026 | Heier Jeffrey S. | Chief Scientific Officer | S-Sale | Disposed | 3,018 | $8.20 |
| 28 May 2026 | Nayak Sanjay | Chief Strategy Officer | S-Sale | Disposed | 1,858 | $8.20 |
| 13 Apr 2026 | Dugel Pravin | director, officer: See Remarks | G-Gift | Disposed | 394,696 | $0.00 |
| 13 Apr 2026 | Dugel Pravin | director, officer: See Remarks | G-Gift | Acquired | 394,696 | $0.00 |
| 25 Feb 2026 | Dugel Pravin | director, officer: See Remarks | S-Sale | Disposed | 20,056 | $8.28 |
| 25 Feb 2026 | Kaiser Peter | Chief Development Officer | S-Sale | Disposed | 2,810 | $8.28 |